HeXun Biosciences Co., Ltd. (TPEX:6986)

HeXun Biosciences Revenue

HeXun Biosciences had revenue of 53.48M TWD in the quarter ending September 30, 2026, a decrease of -5.45%. This brings the company's total for the last twelve months to 305.13M, up 4.92% year-over-year. In the year 2025, HeXun Biosciences had annual revenue of 293.23M with 2.38% growth. That makes HeXun Biosciences the 37,737th largest company in the world by revenue and 1,974th in Taiwan.

• Revenue (ttm): 305.13M
• Revenue Growth: +4.92%
• P/S Ratio: 6.83
• Revenue / Employee: n/a
• Employees: 53
• Market Cap: 2.09B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 282.49M 96.3%
• Other 10.74M 3.7%

Fiscal year ended Dec 31, 2025 See the full HeXun Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	293.23M	6.81M	2.38%
Dec 31, 2024	286.42M	155.85M	119.36%
Dec 31, 2023	130.57M	81.10M	163.95%
Dec 31, 2022	49.47M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error